| mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.018 |
0.9 |
| mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
PD-0332991 |
FIMM |
pan-cancer |
AAC |
-0.022 |
0.9 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
AZD7762 |
GDSC1000 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |